Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diabetes Mellitus Type 1 and 2”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT02023489
What this trial is testing

Lipid and Glycogen Metabolism in Patients With Impaired Glucose Tolerance and Calcium Sensing Receptor Mutations

Who this might be right for
Type 2 Diabetes MellitusPrediabetes (Insulin Resistance, Impaired Glucose Tolerance)Familiar Hypocalcuric Hypercalcemia+2 more
Medical University of Vienna 90
Post-approval studies (Phase 4)Study completedNCT05768191
What this trial is testing

Comparative Efficacy of a Two Daily Mixed Insulin Injection Versus a Basal-bolus Scheme With Human Insulin

Who this might be right for
Type 1 Diabetes
Université NAZI BONI 22
Early research (Phase 1)Study completedNCT04880291
What this trial is testing

First-In-Human Study of GFB-024 in Healthy Overweight and Obese Participants, and Participants With Type 2 Diabetes

Who this might be right for
Kidney DiseasesDiabetic NephropathiesDiabetes Complications+2 more
Goldfinch Bio, Inc. 39
Large-scale testing (Phase 3)Study completedNCT00773279
What this trial is testing

Efficacy, Safety and Preference Study of a Insulin Pen PDS290 vs. a Novo Nordisk Marketed Insulin Pen in Diabetics

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2+1 more
Novo Nordisk A/S 242
Not applicableUnknownNCT02887625
What this trial is testing

Exenatide Plus Pioglitazone Versus Insulin in Poorly Controlled T2DM

Who this might be right for
Type 2 Diabetes
Dr. Muhammad Abdulghani 410
Testing effectiveness (Phase 2)Study completedNCT03514420
What this trial is testing

Study of AKCEA-ANGPTL3-LRx (ISIS 703802) in Participants With Familial Partial Lipodystrophy (FPL)

Who this might be right for
Familial Partial Lipodystrophy
Akcea Therapeutics 4
Early research (Phase 1)Study completedNCT01433380
What this trial is testing

Evaluate PF-05175157 In Healthy Volunteers

Who this might be right for
Diabetes Mellitus, Type 2
Pfizer 22
Testing effectiveness (Phase 2)Study completedNCT05731544
What this trial is testing

Study of BMF-219 in Healthy Adult Subjects and in Adult Subjects With Type 2 Diabetes Mellitus (T2D)

Who this might be right for
Type 2 Diabetes Mellitus
Biomea Fusion Inc. 443
Not applicableLooking for participantsNCT06203106
What this trial is testing

NYSCF Scientific Discovery Biobank

Who this might be right for
ALSAmyotrophic Lateral SclerosisAlzheimer Disease+26 more
New York Stem Cell Foundation Research Institute 10,000
Large-scale testing (Phase 3)Study completedNCT00231387
What this trial is testing

Rosiglitazone And Plaque Study for Type 2 Diabetes Mellitus

Who this might be right for
Non-insulin-dependent Diabetes Mellitus
GlaxoSmithKline 60
Not applicableStudy completedNCT03638349
What this trial is testing

Actions & Insights Evaluating a Novel Diabetes Management Solution

Who this might be right for
Diabetes Mellitus ( Type 1 and Type 2)
LifeScan Scotland Ltd 163
Large-scale testing (Phase 3)Study completedNCT01733758
What this trial is testing

A Monotherapy Study to Evaluate the Efficacy and Safety of 2 Dose Levels of Albiglutide in Japanese Subjects With Type 2 Diabetes Mellitus (T2DM)

Who this might be right for
Diabetes Mellitus, Type 2
GlaxoSmithKline 494
Early research (Phase 1)Study completedNCT01394055
What this trial is testing

Study to Assess Pharmacodynamics of RM-131 in Patients With Diabetic Gastroparesis

Who this might be right for
Diabetes Mellitus Type 1 and 2Diabetes Mellitus ComplicationsGastroparesis+1 more
Motus Therapeutics, Inc. 20
Not applicableStudy completedNCT03259984
What this trial is testing

Epigenetics of Muscle Insulin Resistance

Who this might be right for
Diabetes Mellitus, Type 2Obesity
University of Arizona 72
Early research (Phase 1)Study completedNCT01188863
What this trial is testing

Study of Two Oral Formulations of LX4211 in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Lexicon Pharmaceuticals 15
Early research (Phase 1)Study completedNCT01555008
What this trial is testing

Study to Evaluate the Pharmacodynamic and Pharmacokinetic Effects of LX4211 in Subjects With Type 2 Diabetes and Renal Impairment

Who this might be right for
Type 2 Diabetes MellitusRenal Impairment
Lexicon Pharmaceuticals 31
Not applicableStudy completedNCT01740921
What this trial is testing

GLP-1 and Microvascular Function in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Royal Devon and Exeter NHS Foundation Trust 39
Early research (Phase 1)Study completedNCT01065948
What this trial is testing

A Feasibility Study to Assess Critical Aspects of Fluorescence Affinity Sensor (FAS) Performance and Safety Over Several Hours

Who this might be right for
Diabetes
BioTex, Inc. 12
Not applicableEnded earlyNCT04630925
What this trial is testing

In-hospital Diabetes Management With Flash Glucose Monitoring (isCGM) - the INDIGO Study, Part B

Who this might be right for
Type 1 Diabetes MellitusType 2 Diabetes MellitusDiabetes Mellitus
University of Aarhus 1
Testing effectiveness (Phase 2)Study completedNCT00320021
What this trial is testing

Effect of Pyridorin in Patients With Diabetic Nephropathy

Who this might be right for
Diabetic Nephropathy
BioStratum 80
Next Page